CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM
Ifetroban is being developed as a potential treatment for heart muscle disease linked to Duchenne muscular dystrophy; the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results